149 related articles for article (PubMed ID: 15940635)
1. Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.
Li H; Fu X; Chen Y; Hong Y; Tan Y; Cao H; Wu M; Wang H
Gastroenterology; 2005 Jun; 128(7):2029-41. PubMed ID: 15940635
[TBL] [Abstract][Full Text] [Related]
2. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.
Li X; Pan Y; Fan R; Jin H; Han S; Liu J; Wu K; Fan D
Carcinogenesis; 2008 Aug; 29(8):1587-93. PubMed ID: 18299278
[TBL] [Abstract][Full Text] [Related]
5. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
[TBL] [Abstract][Full Text] [Related]
7. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
8. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma.
Li K; Lin SY; Brunicardi FC; Seu P
Cancer Res; 2003 Jul; 63(13):3593-7. PubMed ID: 12839946
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo.
Zhang SZ; Pan FY; Xu JF; Yuan J; Guo SY; Dai G; Xue B; Shen WG; Wen CJ; Zhao DH; Li CJ
Mol Cancer Ther; 2005 Oct; 4(10):1577-84. PubMed ID: 16227408
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated siRNA inhibited survivin gene expression induces tumor cell apoptosis in nude mice.
Yin K; Liu Q; Zhu S; Yan G
Biosci Trends; 2008 Dec; 2(6):231-4. PubMed ID: 20103933
[TBL] [Abstract][Full Text] [Related]
11. Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth.
Chen T; Xiong J; Yang C; Shan L; Tan G; Yu L; Tan Y
Cancer Gene Ther; 2014 Mar; 21(3):133-8. PubMed ID: 24577129
[TBL] [Abstract][Full Text] [Related]
12. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
Pan Q; Liu B; Liu J; Cai R; Liu X; Qian C
Acta Oncol; 2008; 47(1):135-44. PubMed ID: 17934893
[TBL] [Abstract][Full Text] [Related]
14. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
15. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.
Deng Q; Li KY; Chen H; Dai JH; Zhai YY; Wang Q; Li N; Wang YP; Han ZG
Hepatology; 2014 Feb; 59(2):518-30. PubMed ID: 23929653
[TBL] [Abstract][Full Text] [Related]
16. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.
Zhang H; Tian Y; Shen J; Wang Y; Xu Y; Wang Y; Han Z; Li X
Int J Oncol; 2014 Aug; 45(2):719-31. PubMed ID: 24899407
[TBL] [Abstract][Full Text] [Related]
18. [ShRNA-mediated silencing of MDM2 inhibits growth of HepG2 hepatocellular carcinoma cells xenografted in nude mice].
Zhao YY; Li YG; Sun YJ; Liu HP; Yang ZC; Zhang DD; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):213-7. PubMed ID: 23967744
[TBL] [Abstract][Full Text] [Related]
19. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.
Yao M; Wang L; Yang J; Yan X; Cai Y; Yao D
Tumour Biol; 2016 Nov; 37(11):14677-14686. PubMed ID: 27623941
[TBL] [Abstract][Full Text] [Related]
20. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]